Given the results of KEYNOTE-A18, do you plan to recommend adding pembrolizumab to primary chemoradiotherapy for advanced stage cervical cancer?
If so, will you recommend it universally or only for certain patient population(s)?
Community PollStarted
Are you now incorporating an immune checkpoint inhibitor into the chemoradiation treatment of locally advanced cervical cancer?
278 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on
Until the paper gets published, we won't really know a lot of details that may influence the potential utility of this regimen. It has an abstract/presentation and has recently received FDA approval.
It is a relatively 'newer' idea in improving outcomes that we as an institution are open to start off...
Join for free or sign in to see the full answer